Obesity

Companies: 1,032
Sector: Healthcare
Overview

Obesity is a key segment within the Healthcare sector, comprising 1,032+ companies actively operating in this space.

This segment represents businesses focused on specific activities and services within Healthcare. Companies in this segment share common characteristics, market positioning, and often face similar challenges and opportunities.

Browse the comprehensive directory of Obesity companies to access detailed profiles, financial information, funding rounds, investor details, and other critical business intelligence for research, due diligence, and market analysis.

Top Companies in Obesity

Discover leading companies in this segment, ranked by company performance and market presence.

Allurion
allurion.com

Satiety induction through digestable gastric balloon introduced via a swallowed capsule

Founded 2009
Location Wellesley, Massachusetts, United States
Revenue USD 32.11 M As on 31 Dec 2024
Employees 137 As on 31 Dec 2024
Total Funding USD 174.04 M As on 14 Nov 2025
Adocia
adocia.com

Therapeutics for diabetes and obesity treatment are developed.

Founded 2005
Location Lyon, Auvergne-rhone-alpes, France
Revenue USD 9.68 M As on 31 Dec 2024
Employees 77 As on 31 Dec 2024
Total Funding USD 26 M As on 18 Dec 2025
BioAge Labs
bioagelabs.com

Bioinformatics platform is provided for biomarkers and drug discovery.

Founded 2015
Location Vallejo, California, United States
Employees 64 As on 31 Dec 2024
Total Funding USD 293.9 M As on 13 Feb 2024
Carmot
carmot.us

Disease-modifying therapies for metabolic diseases are developed.

Founded 2008
Location Berkeley, California, United States
Total Funding USD 385.52 M As on 25 May 2023
Structure Therapeutics
structuretx.com

Oral small molecule drugs for chronic diseases are developed.

Founded 2017
Location San Francisco, California, United States
Employees 163 As on 31 Dec 2024
Total Funding USD 233 M As on 01 Aug 2022
Aardark Therapeutics
aardvarktherapeutics.com

Small molecule therapeutics for obesity and metabolic disorders are developed.

Founded 2017
Location San Diego, California, United States
Employees 22 As on 31 Dec 2024
Total Funding USD 138 M As on 01 May 2024
Apollo Endo
apolloendo.com

Therapeutic devices for obesity and GI disorders are developed.

Founded 2005
Location Austin, Texas, United States
Revenue USD 76.86 M As on 31 Dec 2022
Employees 132 As on 31 Dec 2022
Total Funding USD 80.36 M As on 20 Jul 2020
GI Windows
giwindows.com

Nonsurgical endoscopic devices for GI tract anastomoses are developed.

Founded 2012
Location West Bridgewater, Massachusetts, United States
Employees 15 As on 31 Dec 2022
Total Funding USD 91.98 M As on 02 Oct 2024
Metsera
metsera.com

Biopharmaceuticals for obesity and metabolic diseases are developed.

Founded 2022
Location New York, New York, United States
Employees 81 As on 31 Dec 2024
Total Funding USD 505 M As on 12 Nov 2024
Rani Therapeutics
ranitherapeutics.com

Technology for oral delivery of large drug molecules is developed.

Founded 2012
Location San Jose, California, United States
Revenue USD 1.03 M As on 31 Dec 2024
Employees 105 As on 31 Dec 2024
Total Funding USD 234.14 M As on 23 Oct 2025
Juvena Therapeutics
juvenatherapeutics.com

Protein-based therapies for sarcopenia and muscle regeneration are developed.

Founded 2017
Location San Mateo, California, United States
Total Funding USD 75.81 M As on 27 Jun 2025
Lumen
lumen.me

Breath-based metabolism tracker for personalized diet plans is provided.

Founded 2014
Location Ramat Hasharon, Tel Aviv District, Israel
Total Funding USD 77.5 M As on 01 Dec 2022
Nitinote Surgical
nitinotesurgical.com

Non-surgical bariatric solutions for obesity are developed.

Founded 2014
Location Ramat Gan, Tel Aviv District, Israel
Total Funding USD 26.1 M As on 23 Dec 2024
Xeno Biosciences
xenobiosciences.com

Developer of transformational therapies for metabolic diseases

Founded 2015
Location Cambridge, Massachusetts, United States
Total Funding USD 8.42 M As on 05 Jan 2023
Vivus
vivus.com

Developer of therapeutic solutions for obesity and sexual health

Founded 1991
Location Mountain View, California, United States
Revenue USD 69.76 M As on 31 Dec 2019
Employees 59 As on 29 Feb 2020

Developer of small molecule based therapeutics for the treatment of liver, gastrointestinal, and metabolic disorders

Founded 2011
Location Rockville, Maryland, United States
Employees 70 As on 31 Dec 2024
Total Funding USD 107 M As on 05 Jan 2023
Syntis
syntis.bio

Drug compounding services are provided by Syntis in healthcare.

Founded 2021
Location Boston, Massachusetts, United States
Total Funding USD 65.88 M As on 01 Jul 2025

Developing and marketing drugs for the treatment of obesity.

Founded 2002
Location San Diego, California, United States
Employees 132 As on 31 Dec 2016
Total Funding USD 76 M As on 23 Feb 2017
Zealand Pharma
zealandpharma.com

Protein therapies for diabetes and gastrointestinal diseases are developed.

Founded 1998
Location Glostrup, Denmark
Revenue USD 8.73 M As on 31 Dec 2024
Employees 335 As on 31 Dec 2024
Biophytis
biophytis.com

Drugs for neuromuscular and age-related diseases are developed.

Founded 2006
Location Romainville, Ile-de-france, France
Employees 20 As on 31 Dec 2024
Total Funding USD 2.6 M As on 13 Mar 2026

Explore Companies in Obesity

Access detailed company profiles, financial data, funding information, and more for all companies in this segment.

View All Companies